278 related articles for article (PubMed ID: 12657686)
1. Direct cAMP signaling through G-protein-coupled receptors mediates growth cone attraction induced by pituitary adenylate cyclase-activating polypeptide.
Guirland C; Buck KB; Gibney JA; DiCicco-Bloom E; Zheng JQ
J Neurosci; 2003 Mar; 23(6):2274-83. PubMed ID: 12657686
[TBL] [Abstract][Full Text] [Related]
2. Continuous activation of pituitary adenylate cyclase-activating polypeptide receptors elicits antipodal effects on cyclic AMP and inositol phospholipid signaling pathways in CATH.a cells: role of protein synthesis and protein kinases.
Muller A; Lutz-Bucher B; Kienlen-Campard P; Koch B; Loeffler JP
J Neurochem; 1998 Apr; 70(4):1431-40. PubMed ID: 9523559
[TBL] [Abstract][Full Text] [Related]
3. PACAP and VIP stimulate Ca2+ oscillations in rat gonadotrophs through the PACAP/VIP type 1 receptor (PVR1) linked to a pertussis toxin-insensitive G-protein and the activation of phospholipase C-beta.
Hezareh M; Schlegel W; Rawlings SR
J Neuroendocrinol; 1996 May; 8(5):367-74. PubMed ID: 8736436
[TBL] [Abstract][Full Text] [Related]
4. Pituitary adenylate cyclase-activating polypeptides directly stimulate sympathetic neuron neuropeptide Y release through PAC(1) receptor isoform activation of specific intracellular signaling pathways.
Braas KM; May V
J Biol Chem; 1999 Sep; 274(39):27702-10. PubMed ID: 10488112
[TBL] [Abstract][Full Text] [Related]
5. Pituitary adenylate cyclase-activating polypeptide potentiation of Ca2+ entry via protein kinase C and A pathways in melanotrophs of the pituitary pars intermedia of rats.
Tanaka K; Shibuya I; Harayama N; Nomura M; Kabashima N; Ueta Y; Yamashita H
Endocrinology; 1997 Oct; 138(10):4086-95. PubMed ID: 9322916
[TBL] [Abstract][Full Text] [Related]
6. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide stimulate two signaling pathways in CHO cells stably transfected with the selective type I PACAP receptor.
Delporte C; Poloczek P; de Neef P; Vertongen P; Ciccarelli E; Svoboda M; Herchuelz A; Winand J; Robberecht P
Mol Cell Endocrinol; 1995 Jan; 107(1):71-6. PubMed ID: 7796937
[TBL] [Abstract][Full Text] [Related]
7. C2-ceramide and reactive oxygen species inhibit pituitary adenylate cyclase activating polypeptide (PACAP)-induced cyclic-AMP-dependent signalling pathway.
Sée V; Koch B; Loeffler JP
J Neurochem; 2001 Feb; 76(3):778-88. PubMed ID: 11158249
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms mediating pituitary adenylate cyclase-activating polypeptide depolarization of rat sympathetic neurons.
Beaudet MM; Parsons RL; Braas KM; May V
J Neurosci; 2000 Oct; 20(19):7353-61. PubMed ID: 11007893
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of peptide histidine isoleucine (PHI) and related peptides on stimulation and suppression of neuroblastoma cell proliferation. A novel VIP-independent action of PHI via MAP kinase.
Lelièvre V; Pineau N; Du J; Wen CH; Nguyen T; Janet T; Muller JM; Waschek JA
J Biol Chem; 1998 Jul; 273(31):19685-90. PubMed ID: 9677397
[TBL] [Abstract][Full Text] [Related]
10. Pituitary adenylate cyclase-activating polypeptide (PACAP) 38 and PACAP27 activate common and distinct intracellular signaling pathways to stimulate growth hormone secretion from porcine somatotropes.
Martínez-Fuentes AJ; Castaño JP; Gracia-Navarro F; Malagón MM
Endocrinology; 1998 Dec; 139(12):5116-24. PubMed ID: 9832451
[TBL] [Abstract][Full Text] [Related]
11. G-protein-coupled receptor kinase 3- and protein kinase C-mediated desensitization of the PACAP receptor type 1 in human Y-79 retinoblastoma cells.
Dautzenberg FM; Hauger RL
Neuropharmacology; 2001 Mar; 40(3):394-407. PubMed ID: 11166332
[TBL] [Abstract][Full Text] [Related]
12. Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors in the brain.
Shioda S
Kaibogaku Zasshi; 2000 Dec; 75(6):487-507. PubMed ID: 11197592
[TBL] [Abstract][Full Text] [Related]
13. Characterization of PACAP receptors and signaling pathways in rabbit gastric muscle cells.
Murthy KS; Jin JG; Grider JR; Makhlouf GM
Am J Physiol; 1997 Jun; 272(6 Pt 1):G1391-9. PubMed ID: 9227474
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) potentiate the glutamate-evoked release of arachidonic acid from mouse cortical neurons. Evidence for a cAMP-independent mechanism.
Stella N; Magistretti PJ
J Biol Chem; 1996 Sep; 271(39):23705-10. PubMed ID: 8798593
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the presence of receptors for pituitary adenylate cyclase-activating polypeptide in the neurohypophysis that are positively coupled to cyclic AMP formation and neurohypophyseal hormone secretion.
Lutz-Bucher B; Monnier D; Koch B
Neuroendocrinology; 1996 Aug; 64(2):153-61. PubMed ID: 8857610
[TBL] [Abstract][Full Text] [Related]
17. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
18. Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type I astrocytes.
Grimaldi M; Cavallaro S
Eur J Neurosci; 1999 Aug; 11(8):2767-72. PubMed ID: 10457173
[TBL] [Abstract][Full Text] [Related]
19. PAC1 and PACAP expression, signaling, and effect on the growth of HCT8, human colonic tumor cells.
Le SV; Yamaguchi DJ; McArdle CA; Tachiki K; Pisegna JR; Germano P
Regul Pept; 2002 Nov; 109(1-3):115-25. PubMed ID: 12409223
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
